Redhill biopharma ltd. (RDHL)
CashFlow / Quarterly
Jun'18Jun'17
OPERATING ACTIVITIES:
Comprehensive loss

-11,118

-11,023

Adjustments in respect of income and expenses not involving cash flow:
Share-based compensation to employees and service providers

733

705

Depreciation

23

18

Fair value adjustment on derivative financial instruments

-1,667

2,251

Fair value losses on financial assets at fair value through profit or loss

-13

-64

Revaluation of bank deposits

13

87

Exchange differences in respect of cash and cash equivalents

53

-119

Total adjustments in respect of income and expenses not involving cash flow

2,476

-1,670

Changes in assets and liability items:
Increase in trade receivables

13

-778

Decrease (increase) in prepaid expenses and other receivables

188

-421

Increase in inventory

-130

-610

Increase (decrease) in accounts payable

1,299

1,124

Increase (decrease) in accrued expenses and other current liabilities

-1,127

3,650

Total changes in assets and liability items

-243

-2,965

Net cash used in operating activities

-8,399

-9,728

INVESTING ACTIVITIES:
Purchase of fixed assets

2

102

Change in investment in current bank deposits

-5,000

-284

Purchase of financial assets at fair value through profit or loss

42

10,500

Proceeds from sale of financial assets at fair value through profit or loss

1,500

5,447

Net cash provided by (used in) investing activities

6,456

-4,871

FINANCING ACTIVITIES:
Exercise of warrants and options into ordinary shares, net of expenses

-

175

Net cash provided by financing activities

-

175

DECREASE IN CASH AND CASH EQUIVALENTS

-1,943

-14,424

EXCHANGE DIFFERENCES ON CASH AND CASH EQUIVALENTS

-53

119

SUPPLEMENTARY INFORMATION ON INTEREST RECEIVED IN CASH

148

130